The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Fairness to Kids with Cancer Act is introduced in the House

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Six members of the House of Representatives recently introduced the Fairness to Kids with Cancer Act (HR-4429), which seeks to adjust federal funding levels for pediatric cancer at a fairer percentage rate than is currently allocated.

Under the act, the percentage of U.S. citizens under the age of 18 would be used to determine the amount of federal funds for pediatric cancer research. This approach is different from the standard approach of apportioning funds based on scientific opportunity.

Reps. Brian Fitzpatrick (R-PA), Josh Gottheimer (D-NJ), Elise Stefanik (R-NY), Mike Kelly (R-PA), Brendan Boyle (D-PA), and Stephanie Murphy (D-FL) introduced the bill.

Table of Contents

YOU MAY BE INTERESTED IN

Regulatory News

FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial

FDA has granted an accelerated approval to RP1 (vusolimogene oderparepvec) following the agency’s Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.
By Jacquelyn Cobb and Paul Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account